Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
600196
Hisse Senetlerindeki Sıralama
#2198
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical... Shanghai Fosun Pharmaceutical (Group) Co., Ltd. engages in the pharmaceutical business in Mainland China and internationally. It operates through five segments: Pharmaceuticals, Medical Devices and Medical Diagnosis, Medical Services, Medical Distribution and Retail, and Others. The company is involved in the pharmaceutical manufacturing in the therapeutic areas of solid oncology, including tumors and hematologic malignancies, as well as immune-inflammatory disorders, metabolism and digestive systems, anti-infection, central nervous system, cardiovascular system, and APIs and intermediates. It also offers mRNA vaccines; medical aesthetic devices, such as medical aesthetic capital equipment, aesthetic dentistry, injectables, and personal care business units; mechanical ventilation devices under the Breas brand; and mobile pre-hospital care; professional in-hospital surgery and covers medical devices; and high-end surgical robots and medical consumables. In addition, the company provides diagnostics solutions comprising biochemical diagnostics, immune diagnostics, molecular diagnostics, microbiological diagnostics, pathological diagnostics, and chronic care management; and healthcare services, specialized medical treatment, online and offline medical services, and insurance services. Further, it engages in the operation of hospitals; and distribution and retail of healthcare products. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. was founded in 1994 and is based in Shanghai, China.
Hisse Fiyatı
$3.40
Piyasa Değeri
$9.07B
Değişim (1 gün)
-1.61%
Değişim (1 yıl)
-16.08%
Ülke
CN
Ticaret Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196)
Kategori
Healthcare
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196) için gelir
Oct 2026 itibarıyla gelir TTM: 0
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. şirketinin en son finansal raporlarına göre, mevcut geliri (TTM) 0'dir. 2026 yılında şirketin geliri 0 önceki yıla eşit 2026 yılındaki 0 gelirine göre. Gelir, bir şirketin mal veya hizmet satışından elde ettiği toplam tutardır. Kazançtan farklı olarak, hiçbir gider düşülmez.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. için 2001 ile 2026 arasındaki gelir geçmişi
Her yılın sonunda gelir
| Yıl | Gelir | Değiştir |
|---|---|---|
| 2025 | $5.93B | 5.44% |
| 2024 | $5.63B | -3.80% |
| 2023 | $5.85B | -8.21% |
| 2022 | $6.37B | 3.81% |
| 2021 | $6.14B | 32.30% |
| 2020 | $4.64B | 13.01% |
| 2019 | $4.11B | 13.32% |
| 2018 | $3.62B | 27.17% |
| 2017 | $2.85B | 35.20% |
| 2016 | $2.11B | 8.52% |
| 2015 | $1.94B | 0.01% |
| 2014 | $1.94B | 17.81% |
| 2013 | $1.65B | 39.99% |
| 2012 | $1.18B | 14.43% |
| 2011 | $1.03B | 49.06% |
| 2010 | $690.17M | 22.38% |
| 2009 | $563.96M | 1.99% |
| 2008 | $552.97M | 9.32% |
| 2007 | $505.81M | -3.27% |
| 2006 | $522.92M | 41.24% |
| 2005 | $370.24M | 27.18% |
| 2004 | $291.11M | 11.82% |
| 2003 | $260.35M | 108.87% |
| 2002 | $124.64M | 41.71% |
| 2001 | $87.96M | 0.00% |
Benzer şirketler veya rakiplerin geliri
| Şirket | Gelir | Gelir Farkı | Ülke |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | - |
IN
|
